Drug Profile
BW 737C89
Alternative Names: BW 737CLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antipsychotics; Small molecules
- Mechanism of Action Dopamine D1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 06 Dec 2000 Profile reviewed but no significant changes made
- 05 Feb 1997 No-Development-Reported for Psychotic disorders in United Kingdom (Unknown route)